NewsRx

Search our medical news database

Opthalmology

Treatment for wet age-related macular degeneration receives new brand name

Published in Medical Devices and Surgical Technology Week, November 7th, 2004

Photodynamic therapy company Miravant Medical Technologies (MRVT) announced PHOTREX as the new brand name for SnET2, a proposed photodynamic therapy drug for the treatment of wet age-related macular degeneration (AMD).

Miravant also announced that the United States Adopted Name Council (USAN) has designated "rostaporfin" as the drug's unique generic name. USAN is the agency that assigns generic names to pharmaceuticals.

"We believe that PHOTREX is a powerful and distinctive brand name for SnET2 photodynamic therapy," said Gary S. Kledzik, Ph.D., Miravant's chairman and CEO. On Sep. 30, 2004, the U.S. Food and Drug Administration (FDA) issued an...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook